Key points are not available for this paper at this time.
This study estimates the global burden of epilepsy and the proportions with AE, which may benefit from treatment. There are systematic differences in reported prevalence estimates, which are only partially explained by study characteristics.
Ngugi et al. (Thu,) studied this question.